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Abstract: Finding an effective muscle regeneration technique is a priority for regenerative medicine.
It is known that the key factors determining tissue formation include cells, capable of proliferating
and/or differentiating, a niche (surface) allowing their colonization and growth factors. The interaction
between these factors, especially between the surface of the artificial niche and growth factors, is not
entirely clear. Moreover, it seems that the use of a complex of complementary growth factors
instead of a few strictly defined ones could increase the effectiveness of tissue maturation, including
muscle tissue. In this study, we evaluated whether graphene oxide (GO) nanofilm, chicken embryo
muscle extract (CEME), and GO combined with CEME would affect the differentiation and functional
maturation of muscle precursor cells, as well as the ability to spontaneously contract a pseudo-tissue
muscle. CEME was extracted on day 18 of embryogenesis. Muscle cells obtained from an 8-day-old
chicken embryo limb bud were treated with GO and CEME. Cell morphology and differentiation were
observed using different microscopy methods. Cytotoxicity and viability of cells were measured by
lactate dehydrogenase and Vybrant Cell Proliferation assays. Gene expression of myogenic regulatory
genes was measured by Real-Time PCR. Our results demonstrate that CEME, independent of the
culture surface, was the main factor influencing the intense differentiation of muscle progenitor cells.
The present results, for the first time, clearly demonstrated that the cultured tissue-like structure was
capable of inducing contractions without externally applied impulses. It has been indicated that a
small amount of CEME in media (about 1%) allows the culture of pseudo-tissue muscle capable of
spontaneous contraction. The study showed that the graphene oxide may be used as a niche for
differentiating muscle cells, but the decisive influence on the maturation of muscle tissue, especially
muscle contractions, depends on the complexity of the applied growth factors.
Keywords: graphene oxide; in vitro; muscle contraction; myotube formation; tissue extract
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1. Introduction
Tissue engineering is hugely challenging but offers hope for better therapeutic processes after
traumatic muscle injury, tumor ablation, or muscle disease [1]. There is a pressing need within
regenerative medicine to find an effective muscle regeneration technique. Stem cells, growth factors,
and artificial niches are recognized as fundamental elements for tissue engineering [2]. The interaction
between these factors is not entirely clear. Furthermore, the use of a complex of complementary
growth factors instead of a few strictly defined ones could increase the effectiveness of muscle tissue
maturation. In our research, we used chicken embryo muscle precursor cells; chicken embryo muscle
extract (CEME), containing a cocktail of growth factors; and graphene oxide (GO) nanofilm as a
potential niche.
1.1. Muscle Precursor Cells
Skeletal muscles are derived from somites, which are formed from the mesoderm. Somites give
rise to the dermomyotome, myotome, and sclerotome [3]. The cells with myogenic potential are
known as myoblasts, and after they exit the cell cycle, a multinucleated myotube and myofiber form by
fusion [4]. The process of progenitor muscle cell differentiation is controlled by myogenic regulatory
factors (MRFs)—a group of transcription factors comprising Myf5, MyoD, MyoG, and MRF4. MRFs
create a network of auto- and cross-regulatory interactions between factors, which modulate expression
levels [5]. With the exception of Myf5, each factor can individually activate the differentiation of
muscle progenitor cells [6], while Myf5 and MyoD regulate cell proliferation. MyoD is also associated
with the promotion of the myogenic determination process, whereas MyoG is crucial for the terminal
maturation of myoblasts, and inhibition of MyoG expression results in a loss of skeletal muscle [7].
The paired-box transcription factors, Pax3 and Pax7, play an important role in early myogenesis, and
are specific for dermomyotome-derived muscle progenitor cells [8,9]. After activation of MRFs, Pax3
expression is downregulated [10]. Expression of Pax7 is also distinctive for muscle satellite cells in
mature tissue [11].
1.2. Growth Factors
Tissue and embryo extracts have been commonly used in cell cultures in vitro. Skeletal muscle
extract applied to a motoneuron culture enhanced cell survival [12,13] and induced differentiation
in vitro [14]. Extracts from a chicken embryo and chicken embryo eye ensured the survival of embryo
ciliary ganglionic neurons [15]. Chicken embryo extract is widely used as a growth-promoting factor,
as it enhances the proliferation of myogenic cells and affects the timing of the final differentiation [16–18].
It can, therefore, be assumed that the composition of growth factors contained in the muscle of the
embryo, just before hatching, when the body focuses on the preparation of the musculoskeletal system
(leg muscles) for intensive work after hatching, will contain a set of proteins necessary to activate
spontaneous contractions. In the culture of muscle cells, natural substances that stimulate proliferation
or differentiation, such as horse serum [19] or whole embryo extract [16–18,20], are used, but the extract
from the embryo muscle taken at the end of embryogenesis has not been previously used in muscle
cell culture.
1.3. Niches
Carbon-based nanomaterials are promising substrates for reinforcing artificial niches and
mimicking native muscle extracellular matrix [21]. The presence of oxygen-containing groups
on the carbon sheet surface makes GO a non-toxic and biocompatible material [22]. However, the other
physicochemical features of GO can significantly modify its biocompatibility [23,24]. In our studies on
rats, we documented the lack of toxicity of high doses of GO administered into the peritoneum [25,26].
Other authors, although they demonstrated the location of GO in various tissues, especially in the
lungs, nevertheless, pointed to its relative biocompatibility [27].
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Moreover, the physical properties of GO, such as its roughness, surface topography, thickness,
elasticity, and hydrophilicity, can modulate cell behavior and the differentiation process via mechanical
or chemical signaling [28]. Thus, GO can provide authentic extra-cellular stimuli for muscle progenitor
cells. However, this requires GO is kept outside of the cell as part of the matrix.
Many studies have demonstrated the effects of GO on proliferation, adhesion, and the
differentiation of various types of cells [29]. GO enhances the expression of the gene involved
in cardiomyogenic differentiation of human embryonic stem cells in vitro [30]. The application of
the GO complex with a conductive polymer improved neural cell in vitro differentiation [31]. GO
implanted together with chitosan or polylactic acid scaffold were an excellent, biocompatible matrix
for bone mineralization in the process of their regeneration [32,33]. In in vivo studies with the
nanocomposite containing 1% GO, introduced as a subcutaneous implant to rats, it was biocompatible,
and interestingly, exhibited antibacterial properties [34].
GO encapsulated in alginate increased the viability of C2C12 cells [35]. A combination of
peptide-decorated polylactic glycolic acid (PLGA) nanofibers and GO stimulated the differentiation
of C2C12 cells [36], and a nanocomposite of polycaprolactone (PCL) with GO promoted adhesion
and proliferation. Fibroblasts cultured on GO film showed different expression profiles for a focal
adhesion protein, indicating a high affinity of the cells to the GO substrate [37]. A study with a
gelatin-GO nanocomposite demonstrated an improvement in the differentiation process in C2C12 cells
by scaffold-cell interactions only [38], and a similar result was obtained with a PCL-GO scaffold [39].
The aim of this study was to determine whether the use of muscle extract obtained from chicken
embryos prior to hatching would affect the differentiation and functional maturation of muscle
precursor cells and the ability of potential pseudo-tissue muscle to spontaneously contract. The study
used two types of surfaces to perform in vitro culture: standard polystyrene culture plates and plates
covered with GO nanofilm, mimicking a biocompatible niche.
2. Results
2.1. GO Characterization
GO was purchased in the form of an aqueous solution with high stability, a dark brown color,
and a concentration of 4 mg/mL No tendency for GO to agglomerate or precipitate was observed after
6 months. The zeta potential of GO suspended in water at a concentration of 1 mg/mL was 27.1 mV.
Transmission Electron Microscopy (TEM) imaging was used to assess the morphology of the flakes of
GO (Figure 1A). After drying, GO formed flakes one to three layers thick and 2 to 4 µm in size.
Fourier Transform Infrared Spectroscopy (FT-IR) analysis revealed a broad, very intense, structured
band that was located at 3457 cm−1 with shoulder maximum at 3217 cm−1 in the graphene IR spectrum.
There were two bands generated by C-H stretching at 2817 and 2779 cm−1. The region at 1800–1500 cm−1
contained two distinct bands generated by C=O stretching (1728 cm−1) and C=C ring stretching
(1621 cm−1). Bending vibrations generally located at a lower energy in the fingerprint spectral region
were at 1367 and 1061 cm−1 (Figure 1B).
2.2. GO Nanofilm Characterization
An aqueous GO solution with a concentration of 1 mg/mL was used to prepare the nanofilm for
in vitro studies. Atomic Force Microscopy (AFM) analysis of GO as a nanofilm on the bottom of a
culture-plate well was performed. Numerous sharp peaks were present on the surface of the culture
plate (Figure 2A). GO nanofilm caused a decrease in the average roughness of the culture plate surface.
The average roughness of GO nanofilm was 1.5 to 2.1 nm, whereas the roughness of the standard
polystyrene culture plate was 7.2 nm. The topography of the nanofilm was irregular and crested
(Figure 2B). The surface coated with GO nanofilm was more aligned and the peaks were rounded and
less jagged compared to the surface of the culture plate.
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Figure 1. (A) Transmission electron microscopic images of graphene oxide flakes at increasing 
magnification: 1) 5,000, 2) 8,500, 3) 34,000, 4) 70,000; (B) Fourier Transform Infrared Spectroscopic 
spectrum of graphene oxide with the assignment of bands to appropriate vibrations of groups and 
bonds present in the sample. 
2.2. GO Nanofilm Characterization 
An aqueous GO solution with a concentration of 1 mg/mL was used to prepare the nanofilm for 
in vitro studies. Atomic Force Microscopy (AFM) analysis of GO as a nanofilm on the bottom of a 
culture-plate well was performed. Numerous sharp peaks were present on the surface of the culture 
plate (Figure 2A). GO nanofilm caused a decrease in the average roughness of the culture plate 
surface. The average roughness of GO nanofilm was 1.5 to 2.1 nm, whereas the roughness of the 
standard polystyrene culture plate was 7.2 nm. The topography of the nanofilm was irregular and 
crested (Figure 2B). The surface coated with GO nanofilm was more aligned and the peaks were 
rounded and less jagged compared to the surface of the culture plate. 
Figure 1. (A) Transmission electron microscopic images of graphene oxide flakes at increasing
magnification: 1) 5,000, 2) 8,500, 3) 34,000, 4) 70,000; (B) Fourier Transform Infrared Spectroscopic
spectrum of graphene oxide with the assignment of bands to appropriate vibrations of groups and
bonds present in the sample.
2.3. Chicken Embryo Muscle Extract Analysis
The mass spectrometry analysis of muscle samples identified 1470 proteins and 6893 unique
peptides (Table S2), which are available in the PRIDE repository under PXD015146. In preliminary
studi s, which allowed the emergence of spectacular pro-contraction activity of CEME, various
substances and extracts were studied, which were a cocktail of growth factors, including horse serum,
embryo brain extract, embryo extract, or liver extract. The spontaneous contraction was observed
only under the influence of CEME, none of the mentioned substances had the effect on contractions of
embryonic muscle cells. Consequently, further morphological and molecular studies were conducted
using a functionally effective factor, which CEME proved to be.
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Figure 2. Atomic Force Microscopy (AFM) mages and a topography model of the surface of a culture 
plate (A) and graphene oxide nanofilm (B). 
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COL6A2 Collagen alpha-2 (VI) chain   58.7 
A0A1D5PME9 Leucine rich repeat containing 15 50.3 
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LOC107050758 Collagen alpha-1 (II) chain 13.1 
COL14A1 Collagen alpha-1 (XIV) chain 11.2 
Figure 2. Atomic Force Microscopy (AFM) mages and a topography model of the surface of a culture
plate (A) and graphene oxide nanofilm (B).
However, in order to identify the potential proteins responsible for muscle cell contraction,
the proteins comm n to CEME and liver extract were rejected, resulting in the number of 249 protein
candidates for top proteins in the muscle cell contraction process. Table 1 presents 59 selected top
proteins associated with muscle contractions to the greatest extent.
Proteins specific only for CEME were selected and grouped according to the relationship of their
function to extracellular matrix (ECM) components, cell structure and communication, and contraction
phenomenon and enzymes related to muscle cell energy metabolism (Table 1). These proteins were
sel cted as potential stimulators of muscle progenitor cell differentiation and maturation.
2.4. Assessment of Proper Concentration of Chicken Embryo Muscle Extract Supplement for in Vitro
Experiment
To assess the optimum concentration of extrac added to the culture media, a Trypan Blue assay
was performed. The number of live cells after 48 h of culture with different concentrations of extract
(5%, 2.5%, and 1%) was measured. In the control group, the viability was 75.5%. In the group with 5%
extract, the viability was 42%. A decrease in the concentration of extract resulted in increased the live
cell count. I the groups with 2.5% and 1% extract addition to the culture media, cell viabilities of 62%
and 82.5% were observed, respectively. The viability of cells with 1% supplementation of CEME was
the highest. Consequently, in further experiments 1% CEME addition was applied.
2.5. Cell Morphology
The microscopic images of the experimental cultured cells show several morphological changes
compared to the control group (Figure 3). Cells cultured on the GO nanofilm were strongly attached to
the substrate; they were more stretched and flatter with numerous filopodia (Figure 3C, [GO]), and
the cell surfaces were gently corrugated. Cells cultured with th extract formed several dense layers,
and there were numerous long, branched, multinucleated myotubes at the top (Figure 3A, [CEME]).
The myotubes were positioned in an unorganized manner, crossing at various angles (Figure 3A,
[CEME]). Myotubes were often longer than 1000 µm and were 10–20 µm wide. Fluorescent images
revealed the striated structure of the myotubes and confirmed the presence of multinucleated muscle
cells (Figure 4A, [CEME]). Fusion index increased significantly in cultures with CEME supplementation,
compared to that in the control group (Figure 4B). The combination of the GO nanofilm with the extract
induced the presence of an undifferentiated multilayer of cells with multinucleated myotubes on the
top. The myotubes on GO nanofilms were positioned in a more organized manner (Figure 3A, [GO]).
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Table 1. Selected top proteins (59) from chicken embryo muscle extract specific for muscle cell activity.
Gene Name Protein Name Molecular Weight [kDa]
Extracellular matrix component
DCN Decorin 61.2
LAMB1 Laminin subunit beta-1 59.4
COL6A2 Collagen alpha-2 (VI) chain 58.7
A0A1D5PME9 Leucine rich repeat containing 15 50.3
FMOD Fibromodulin 44.7
OGN Mimecan/Osteoglycin 42.8
A0A1D5PVT6 Collagen type XI alpha 1 chain 36.4
LMNB1 Lamin-B1 31.6
PLOD1 Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 22.0
COL1A1 Collagen alpha-1 (I) chain 16.1
COL6A3 Collagen alpha-3 (VI) chain 14.6
LOC107050758 Collagen alpha-1 (II) chain 13.1
COL14A1 Collagen alpha-1 (XIV) chain 11.2
LABM1 Laminin subunit beta-1 10.4
Cell structure and communication
PXN Paxillin 66.6
P09652 Tubulin beta-4 chain 61.7
PTK7 Inactive tyrosine-protein 53.7
MAPT Microtubule-associated protein 51.3
CRYAB Alpha-crystallin B chain 50.3
MAPRE2 Microtubule-associated protein RP/EB family member 2 41.7
CDH13 Cadherin-13 40.4
COTL1 ADF actin binding protein 36.9
DMD Dystrophin 24.1
ZYX Zyxin 20.5
WIPF1 WAS/WASL interacting protein family member 1 18.8
CTNNA2 Catenin alpha-2 18.4
Tubulin alpha chain 13.0
NHLRC2 NHL repeat-containing protein 2 12.4
CAP2 Adenylyl cyclase-associated protein 11.7
ACTG1 Actin, cytoplasmic 2 11.7
SPTB Spectrin beta chain 10.4
JUP Plakoglobin 9.92
DBN1 Drebrin 9.37
ACTN2 Alpha-actinin-2 8.02
Contractile apparatus
MYL3 Myosin light chain 62.2
CALD1 Caldesmon 61.4
CAMK2D Calcium/calmodulin-dependent protein kinase type II deltachain 55.3
CNN3 Calponin 51.3
MYLK Myosin light chain kinase, smooth muscle 40.5
MYLPF Myosin regulatory light chain 2, skeletal muscle isoform 37.0
TPM1 Tropomyosin alpha-1 chain 20.7
CASQ2 Calsequestrin 19.5
TNNC2 Troponin C, skeletal muscle 19.3
MYH1B Myosin-1B 11.4
Neural and neuromuscular communication
NEFM Neurofilament medium polypeptide 46.2
AGRN Agrin 46.1
TXLNB Beta-taxilin 31.8
FABP5 Fatty acid binding protein 5 23.4
GAP43 Neuromodulin 18.8
NCAM1 Neural cell adhesion molecule 15.1
Metabolism
ATP5C1 ATP synthase subunit gamma 53.3
GMPR GMP reductase 49.9
GPD2 Glycerol-3-phosphate dehydrogenase 45.5
PFKM ATP-dependent 6-phosphofructokinase 43.8
ADSSL1 Adenylosuccinate synthetase isozyme 1 43.6
CKM Creatine kinase M-type 43.3
AMPD1 AMP deaminase 25.2
A0A1D5PIQ5 Mitogen-activated protein kinase 11.4
CKB Creatine kinase B-type 5.62
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Figure 3. Cell morphology evaluated by optical microscopy (A, B) and scanning electron microscopy 
(C); the images show the control group (CTRL), cells cultured on graphene oxide nanofilm (GO), cells 
cultured with the addition of the extract (CEME), and cells cultured on GO nanofilm with addition of 
the extract (GO + CEME); cells were stained with eosin/hematoxylin for visualization of nucleic acids 
and proteins (B); myotubes (yellow arrows), filopodia (green arrow); multilayer of undifferentiated 
cells (blue arrows). 
. e l orphology evaluated by optical microscopy (A,B) and scan ing electron micr scopy
s sho the control group (CTRL), cells cultured on graph ne oxide anofilm (GO), cells
it t e addition of the extract (CEME), and cells cultured on GO anofilm with additi n of
t t t ( CEME); cells were stained with eosin/hematoxylin for visualization of nuclei acids
r t i s ( ); yotubes (yellow arrows), filopodia (green arrow); multilayer of undifferentiated
cells ( l e rr s).
The key result was the spontaneous contraction activity of myotubes in the cultures with
extract supplementation (Video S1). One to three contractions per minute were noted, an average
of 1.7 contraction per minute. Rhythmic contractions of primary muscle fibers were observed under
the influence of CEME, both in the group without the GO nanofilm as well as with the GO nanofilm.
Moreover, there was no difference in contractions between the cells of the CEME and GO + CEME
groups. There were no contractions in the control and GO groups. Thus, only the growth factor
cocktail (CEME), not the substrate characteristics, generated the physiological activity of cells involved
in myogenesis.
2.6. Cytotoxicity and Viability of Muscle Cells
To evaluate the cytotoxicity of GO nanofilm and the addition of the extract, the lactate
dehydrogenase (LDH) assay was performed after 48 and 96 h of culture (Figure 5A,B). The test
was based on the enzymatic reduction of NAD+ by LDH released from damaged cells into the culture
media. LDH levels reflect the integrity of the cell membrane. Compared to the control group, the
presence of GO nanofilm slightly elevated LDH release from cells after 48 h of culture, but there were
no significant differences after 96 h.
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Figure 4. (A) Fluorescent images with labeled nuclei (blue) and actin (red) of cells after 5 days of 
culture: control group (CTRL); culture with chicken embryo muscle extract supplementation (CEME); 
nuclei in myotubes (green arrows), myotubes (grey arrows), striated sarcomeric structure (yellow 
arrow); quantitative analysis of the fusion index of the differentiating cells (B). The error bars 
represent standard deviations. Different letters (a, b) above the columns indicate statistically 
significant differences between the groups (p ≤ 0.05). 
The key result was the spontaneous contraction activity of myotubes in the cultures with extract 
supplementation (Video S1). One to three contractions per minute were noted, an average of 1.7 
contraction per minute. Rhythmic contractions of primary muscle fibers were observed under the 
Figure 4. (A) Fluorescent images with labeled nuclei (blue) and acti (red) of cells after 5 days of culture:
control group (CTRL); culture with chicken embryo muscle extract supplementation (CEME); nuclei
in myotubes (green arrows), my tubes (grey arrows), striated sarcom ric structu e (yellow arrow);
qu ntitative analysis of the fusion index of the differentiating cells (B). The error bar represent standard
deviations. Different letters ( , b) above the columns indicate st tistically significa t d fferences be ween
the groups (p ≤ 0.05).
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2.7.  Expression of Genes  
Changes in gene expression at the mRNA level were examined using the Real-Time PCR 
method. Compared to the control group, GO nanofilm had no significant effect on the expression of 
genes related to basic metabolism and proliferation—ATP5B, FGF2, LDH5, and PCNA. The extract 
supplementation resulted in a significantly increased level of ATP5B gene expression, whereas FGF2 
Figure 5. Lactate dehydrogenase (LDH) release (A,B) and cell viability (C,D) were determined using
LDH and MTT assays, respectively. Tests were performed after 48 and 96 h of primary culture. Negative
control for LDH maximum release (Triton X), control group (CTRL), cells cultured on graphene oxide
nanofilm (GO), cells cultured with addition of the extract (CEME), and cells cultured on GO nanofilm
with addition of the extract (GO + CEME). The error bars represent standard deviations. Different
letters (a, b, c, d) above the columns indicate statistically significant differences between the groups
(p ≤ 0.05).
To compare the effect of GO nanofilm and CEME on cell viability, the ability of cells to reduce
tetrazolium salt (MTT) and produce insoluble formazan crystals was tested. MTT reduction was
measured after 48 and 96 h of culture (Figure 5C,D). Compared to the control group, GO nanofilm
slightly affected cell viability but the differences were negligible.
2.7. Expression of Genes
Changes in gene expression at the mRNA level were examined using the Real-Time PCR method.
Compared to the control group, GO nanofilm had no significant effect on the expression of genes related
to basic metabolism and proliferation—ATP5B, FGF2, LDH5, and PCNA. The extract supplementation
resulted in a significantly increased level of ATP5B gene expression, whereas FGF2 and LDH5 gene
expression was downregulated in comparison to the control. PCNA gene expression was not influenced
by any factor. The combined presence of the GO nanofilm and the CEME had a significant positive
effect on ATP5B gene expression. FGF2 and LDH5 genes were downregulated in comparison to the
control group, which is similar to the results obtained with the addition of extract only (Figure 6A).
Compared to the control group, the presence of GO nanofilm had no significant effect on expression
at the mRNA level for all genes associated with the differentiation process-Myf5, MyoD1, MyoG, or
Pax3 and Pax7 genes. The addition of extract to the culture media significantly increased the level
of mRNA of Myf5, MyoD1, MyoG, Pax3, and Pax7. The expression profile of cells cultured on GO
nanofilm with the addition of extract was also upregulated in all investigated genes; however, the fold
change was lower than that in the extract-only group (Figure 6B).
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Figure 6. Real-Time PCR analysis of gene expression at the mRNA level in muscle progenitor cells
from the chicken embryo after 5 days of primary culture. Expression of genes related to proliferation,
basic metabolism (A), and muscle cells differentiation (B) was investigated; the figure shows the results
for the control group (CTRL), cells cultured on GO nanofilm (GO), cells cultured with addition of the
extract (CEME), and cells cultured on GO nanofilm and extract (GO + CEME); Relative expression was
calculated using housekeeping genes, ACTB and GAPDH; the results are presented as 2-∆∆CT values
compared to the control group; different letters above the columns indicate statistically significant
differences between the groups (p ≤ 0.05). The error bars represent standard deviations.
3. Discussion
Physiologically fully mature muscle cells that form muscle-like tissue through muscle fiber
cooperation should be capable of spontaneous contractions. Previous research has demonstrated that
it is possible to create muscle-like tissue that is capable of twitching under the influence of externally
applied electrical impulses [22,40,41]. The study presented here is the first to document the generation
of in vitro muscle cell contraction using only selected growth and regulatory factors. Furthermore,
we found that this effect did not depend on the physicochemical characteristics of the cell culture
surface but solely on the availability of protein molecules, i.e., growth factors and their regulators.
To verify our findings, we used two variables for in vitro culture: a differentiated surface and a
differentiated medium.
The surface of the in vitro culture plate was modified by covering with a thin layer of GO. When
the surface of the plate and the GO layer were compared, the GO layer presented a smoother surface
with a lower density of wrinkles and moderate roughness [42]. However, the roughness of GO depends
on many factors and is likely to be variable [43,44]. Using a thin layer of GO, the carbonaceous
biocompatible material can be coated onto the surface of an in vitro culture vessel, and this has proven
to be a reliable, repeatable, and sterile method.
In general, cells maintained on GO nanofilm exhibit normal muscle cell and muscle-cell precursor
morphology. However, we observed more stretched and wrinkled cell surfaces and numerous
protrusions, which could be related to the structure of the GO nanofilm [29] or to the surface chemistry.
A toxic effect and the reduction of proliferation of GO cultured cells were observed only after
48 h. After 96 h of incubation, no harmful effect on GO surface was observed. This phenomenon may
have resulted from the interaction between cells and GO, and as a result of depositing on the GO
surface proteins secreted by muscle precursor cells and by the optimization of the niche conducive to
colonization. The lack of a negative GO effect on muscle and myogenic cells is also confirmed by other
studies [39,44–47].
The presence of GO nanofilm in cell culture did not affect LDH or ATP5B gene expression at the
mRNA level. These basic markers of metabolism, particularly oxygen and anaerobic metabolism,
indicate that the GO nanofilm is neutral to muscle cells and precursors despite the presence of
oxygen groups on the surface. However, in a study on the MFC-10A cancer cell line, the presence of
PEG-modified GO nanosheets downregulated the expression of proteins involved in the oxidative
phosphorylation, but this effect was not observed in non-cancerous cells [48]. Furthermore, our research
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demonstrated that the presence of GO nanofilm has no effect on MyoD1, Myf 5, MyoG, Pax3, and Pax7
gene expression. Expression of these genes is an important determinant of myogenesis—the basic role
of muscle cells and their precursors. This indicates that GO biological activity is probably influenced
by the type of cells.
The second experimental factor was the modification of the culture medium. CEME was used as
an additive to improve the standard medium (DMEM). We expected the extract from an 18-day-old
chicken embryo hind limb to complement the stimulation of muscle progenitor cell differentiation and
physiological maturation. This speculation was based on the fact that the extract contained proteins
involved in the differentiation of muscle cells, which is at a very advanced stage on the 18th day
of embryonic development. Furthermore, the extract contained proteins produced by muscle cells
and their precursors, as well as all other cells present in the developing muscle tissue that cooperate
with the muscle cells. The extract contained proteins involved in preparing the muscles for intense
work, which must occur just before and immediately after hatching, and these proteins are released by
muscle cells particularly [49]. In addition, muscle cells secrete hundreds of proteins and peptides upon
contraction [50].
The addition of the extract strongly affected chicken muscle progenitor cell morphology.
A significantly higher fusion index was noted. We observed elongated, multinucleated, branched, and
striated myotubes, which exhibit spontaneous contractile activity, and these features are typical of
differentiated cell morphology [29,51,52]. These results clearly show that the differentiation process
occurred and that the addition of extract to the culture media led to the formation of a tissue-like
structure of muscle cells and their precursors. However, the resulting myostructure exhibited two layers:
in vivo-like muscle fibers and flat, round, mononuclear cells lining the bottom of the culture vessel.
These cells probably had myogenic potential, as was seen when an undifferentiated subpopulation of
cells was added to a primary culture of rat muscle cells [53].
The observation of cell morphology has been confirmed by cytotoxicity and viability results.
The LDH release from cells did not decease, while the addition of extract significantly increased the
number of viable muscle cells and their precursors after 96 h of culture. This was also noted after
treatment of a skeletal muscle cell culture with extract that was obtained from 12-day-old chicken
embryo brain and liver [54]. In a muscle cell culture obtained from 10-, 11-, and 12-day-old chicken
embryos, the addition of chicken embryo extract showed a stimulatory effect on proliferation and
differentiation [17,55]. Moreover, the addition of chicken embryo extract in combination with high
serum content in the culture media enhanced the proliferation and growth of murine myoblasts [56].
In cells maintained in culture media with CEME, Pax7 expression was strongly upregulated.
Pax7 is a key factor in satellite cell myogenic determination. Deletion of the Pax7 gene resulted in a
significant decrease [57] or complete elimination of satellite cell populations [58], but inactivation of the
Pax7 gene did not affect adult myogenesis [48]. An analysis of the expression profile of Pax3 and Pax7
in rat muscle cells indicated that the level of Pax7 gene expression decreased during the maturation
of myoblasts and formation of myotubes, contrary to our observation that Pax7 was stimulated in
parallel with the up-regulation of the genes responsible for differentiation. In an experiment with rat
muscle cells, a subpopulation of undifferentiating, proliferating cells with Pax3 and Pax7 expression
was also observed [58]. This phenomenon could explain the high expression of Pax3 and Pax7, which
could be related to the dense multilayer of undifferentiated cells that were observed on the bottom
of the culture plate and became a renewable source of differentiating myoblasts. This would explain
the simultaneous and strong increase in the expression of genes responsible for the differentiation of
muscle cells and their precursors into muscle fibers, together with the self-renewal of the pool of cells
that are the early precursors of myocytes.
The addition of CEME to the culture media has a strong effect on MFRs expression. The results
obtained in this study demonstrated that supplementation of the culture media with the extract
enhanced the myogenic differentiation of chicken muscle progenitor cells. We observed a significant
up-regulation of expression of all investigated MRFs (Myf5, MyoD, and MyoG) in cells maintained
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in media with CEME. MRFs are critical factors in the maturation of muscle cells [59,60]. Moreover,
the expression of FGF2, which is considered to be a stimulator of proliferation and a strong inhibitor of
differentiation [61], was downregulated in cells cultured with the extract. From a molecular point of
view, downregulation of FGF should be coupled with downregulation of Pax 7, however, in the case of
heterogeneous culture, which is the primary culture of cells taken from the embryo muscle, expression
of mRNA is a resultant expression of the sum of different cells. It should also be taken into account that
the chicken embryo muscle undergoes very strong myogenesis just before hatching, but also it contains
over 30% of satellite cells [52], whose proteome may promote the proliferation of satellite cells in the
culture. Therefore, primary culture, which on the one hand, well reproduces the natural conditions of
myogenesis, on the other hand, creates difficulties in interpreting the results. It can certainly be stated
that a precise explanation of the above mechanisms requires wider and more precise research.
Differentiation of myoblast cells and their precursors into mature muscle fibers was also confirmed
by the change in cellular metabolism from anaerobic processes to the predominance of oxidative
phosphorylation. LDH gene expression decreased and ATP5B gene expression simultaneously increased
in cells that were cultured with the extract. The results are in agreement with changes occurring in
muscle cells during differentiation, when a high glycolytic state in the myoblasts transforms into
intensive oxidative phosphorylation in mature muscle cells [62].
The morphology and molecular status of differentiating cells, as well as their metabolism profile,
undoubtedly indicate the formation of a structure containing mature muscle cells under the influence
of CEME proteins. However, equally important evidence for the physiological maturity of the structure
is its ability to undergo spontaneous contractions. The present results, for the first time, clearly
demonstrated that the cultured a tissue-like structure was capable of inducing contractions that were
not caused by external factors.
Use of the embryonic muscle extract affected the physiological ability of the muscle cells to contract,
regardless of the type of surface (with or without GO) used. The extract contained proteins derived from
various muscle-related tissues, including nervous tissue, connective tissue, blood vessels, and blood,
as well as various structural proteins, such as of the ECM, cytoplasm, contractile proteins, and neural
structures and their regulators, e.g., metabolic enzymes. These proteins acted as agents to directly
stimulate muscle contractions or as factors to indirectly create an optimal contraction environment.
ECM proteins, especially collagen alpha 1 and alpha 3, decorin, laminin, and fibromodulin, can
affect ECM maturation and cooperation with muscle cells. Laminin controls the structural integrity of
muscle tissue and the connection of the intracellular actin structure with ECM [63–65], and fibromodulin
is a regulatory factor for myoblast differentiation [66].
The extract was also the source of many proteins responsible for ECM–cell–cytoskeleton interactions.
Some proteins form important links with actin-containing filaments of the cytoskeleton [67,68]. However,
it seems that the key proteins are those that directly participate in muscle contraction, i.e., motor proteins
and their regulators (myosin light chain, myosin-1B, myosin regulatory light chain 2, myosin light
chain kinase). Tropomyosin alpha-1 chain–actin-binding protein cooperates with troponin C and is
involved in the contractile system of vertebrate striated muscles. Troponin C and tropomyosin form
thin fibers, which act to bind Ca2+ during the contraction process [69]. Calcium-calmodulin-dependent
protein kinase II with mitogen-activated protein kinase can activate myosin light chain kinase [67].
In addition, it can be assumed that the proteins responsible for the management of Ca ions during
muscle contractions activate this process in vitro. Calsequestrin (a calcium-binding protein responsible
for Ca homeostasis after muscle contraction) supports the storage of a large amount of Ca ions within
the sarcoplasmic reticulum. Before birth, the levels of calsequestrin in the muscles increase rapidly [68],
indicating that it also stimulates muscle physiological maturation.
Furthermore, CEME components are associated with the nervous system and
neural/neuromuscular communication and could be the key to spontaneous muscle cell contraction
in the absence of electrical impulses. A recent study revealed that neuromodulin (specific to the
nervous system) is present in myoblasts, differentiating muscle cells, and mature muscle fibers [70].
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Neural cell adhesion molecule is associated with the fusion of myoblasts, and its level increases
during myoblast differentiation. Agrin is a protein critical to neuromuscular junction development
and maintenance [71], and utrophin is present in neuromuscular and myotendinous junctions and
vasculature [72]. The administration of proteins involved in the cooperation of muscle cells and
nerves, especially signal induction, may have been important for the activation and duration of
the contractions.
Muscle contractions also require energy; therefore, the proteins involved in ATP metabolism
would, undoubtedly, facilitate contraction mechanisms. The presence of ATP synthase subunit gamma,
responsible for producing ATP from ADP, is fundamental. In addition, creatine kinase (CK), which
catalyzes the transfer of a phosphate group from phosphocreatine to ADP to regenerate ATP, is a key
enzyme for cellular ATP homeostasis. Interestingly, the CEME provided a source of both muscle- and
brain-specific forms of CK.
Finally, it has to be underlined that the present measurements elucidated the potential effects of
a variety of proteins and cells from CEME cultivated on GO surface, thereby including interactions
in-between released proteins. However, a further step is necessary to identify groups of key proteins
directly affecting tissue development by interacting in a heterogeneous environment of muscle tissue.
This quantification might help to develop the solutions for future clinical therapy.
4. Materials and Methods
4.1. Characterization of Graphene Oxide and Preparation of a Graphene Oxide Nanofilm
GO water solution (4 mg/mL) was purchased from NanoPoz (Poznan´, Poland), and GO was
produced by a modified Hummers’ method. The obtained GO flakes had diameters of between 2
and 30 µm, an average size of ~4 µm, and contained 36% oxygen (manufacturer’s data). Chemical
characterization of GO was performed with FT-IR. Spectra were registered with the use of a Perkin
Elmer System 2000. The roughness of GO was measured by AFM, and imaging was performed on an
MFP 3D BioAFM with the commercial triangular cantilever (MPLCT, Bruker, Camarillo, CA, USA),
spring constant k = 0.10 N/m in AC mode. The measurements were performed on 10 × 10 µm areas, in
ten places. The shape and size of GO films were examined using a TEM - JEM-1220 (JEOL, Tokyo,
Japan) at 80 kV and a TEM CCD Morada 11 megapixels camera (Olympus Soft Imaging Solutions,
Munster, Germany). The zeta potential and size of GO in solution were measured by light scattering
using a ZetaSizer Nano ZS model ZEN3500 (Malvern Instruments, Malvern, UK). All measurements
were repeated three times.
Experimental GO nanofilm was prepared by applying a GO solution to the bottom of a well in a
culture plate. GO was air dried in a laminar chamber. For nanofilm preparation, a concentration of
1 mg/mL was used. The GO solution was sonicated for 30 min before the experiment. Then, under
sterile conditions, the GO solution was embedded onto the bottom of the culture plate (40 µg) and
dried at room temperature in a laminar chamber. As a result of the self-assembly and drying process,
the plastic bottom of the well was covered with a thin, strongly adhesive nanofilm of GO. The prepared
plates were used for further experiments.
4.2. Chicken Embryo Muscle Extract Preparation
Fertilized chicken (Ross 308) eggs were purchased from a certificated hatchery, sterilized in
KMnO4 solution, irradiated with UV for 45 sec, and incubated at 37 ◦C and ~60% relative humidity.
The tissue sample was obtained from an 18-day-old chicken embryo. The egg was removed from
the incubator and slightly opened, and the embryo was pulled from the egg and decapitated. Then
the explant from the hind limb was dissected, and the skin, bones, and shank were removed from
the muscle tissue sample. A sample was then suspended in ultrapure water and homogenized with
frozen metal balls in a TissueLyser ball mill (Qiagen, New York, NY, USA). The homogenate was
centrifuged at 1400× g for 45 min at 4 ◦C. The supernatant was transferred into a new tube and stored
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at −80 ◦C. In order to reject the proteins contained in CEME, which are not involved in the activation
of muscle contraction, an extract of chicken embryo liver was also prepared according to the method
described above.
The protein composition of the extract was analyzed by mass spectrometry (MS) using an Orbitrap
Elite (Thermo Fisher Scientific, Massachusetts, MA, USA) connected to a Water Acquity HPLC. Protein
extract (150 µL) was concentrated on Vivacon 500, 10,000 MWCO Hydrosart filters by centrifuging
at 10,000× g for 30 min at 4 ◦C. Filters were washed twice with washing buffer (200 µL, 8 M urea in
100 mM NH4HCO3 aqueous solution) and centrifuged at 10,000× g for 20 min at 4 ◦C. Accordingly, the
proteins were reduced by the addition of washing buffer (50 µL) with 20 mM TCEP and incubated for
30 min at room temperature, then centrifuged at 10,000× g for 20 min at 20 ◦C. Proteins were alkylated
with 20 mM IAA (50 µL) in washing buffer. Digestion was performed with a protease mix, LysC/Tryp
V507A (Promega, Wisconsin, WI, USA). The protease mix was resuspended in 8M urea in 100 mM
NH4HCO3 (80 µL). A 40 µL aliquot of the solution was added to a filter and incubated for 3 h at
37 ◦C; then NH4HCO3 (400 µL) was added and the samples were incubated overnight at 37 ◦C. Probes
were centrifuged at 10,000× g for 30 min at 30 ◦C. NH4HCO3 (100 µL) was added and centrifuged at
10,000× g for 30 min at 30 ◦C. The solution was acidified with TFA to a final concentration of 0.4% and
dried with a speed-vac. The peptide mixture was fractionated using a high pH protocol on an Oasis
HLB 10 mg cartridge (Waters 186000383). Cartridges were activated by washing with methanol and
equilibrated with 25 mM ammonium formate at pH 10. The protein pellet was resuspended in 400 µL
of 25 mM ammonium formate at pH 10 and loaded onto a cartridge. Samples were washed once with
loading buffer. The elution was carried out with an increasing gradient of acetonitrile in loading buffer
(5/10/15/20/30/35/40/85). The last elution was carried out with pure methanol. All fractions were dried
with a speed-vac. Pellets were resuspended in 60 µL of 0.1% TFA with 2% MeCN. MS analysis was
performed by LC-MS in the Laboratory of Mass Spectrometry (IBB PAS, Warsaw) [73]. Data were
analyzed on the Max-Quant 1.6.3.4 platform [74,75]. The Gallus gallus reference proteome database
from UniProt (containing 29474 protein IDs) was used. Data were deposited in the PRIDE repository
under PXD015146. To analyze the function of the proteins contained in CEME, the composition of
CEME proteins and the composition of liver extract proteins were compared, and then for further
interpretation, all proteins common to CEME and liver extract were rejected from the CEME proteome.
In this way, proteins that were not involved in the activation of contraction were eliminated, and
only those that were potentially responsible for muscle contraction were left. This procedure was
authorized by a preliminary study, where the lack of effect of the liver extract on muscle cell contraction
was documented.
4.3. Primary Cell Cultures of Muscle Progenitor Cells
Fertilized chicken (Ross 308) eggs were incubated in accordance with the method described in the
section “Chicken embryo muscle extract preparation”. Mesenchymal muscle precursor cells were obtained
from an 8-day-old chicken embryo limb bud by dissection of the hind limb. The sample was inserted
into tubes with trypsin for 24 h at 4 ◦C. The enzyme was then neutralized with culture medium, the
sample was disintegrated by gentle pipetting through the tips, and cells were seeded onto a culture
plate. Cells were maintained in Dulbecco’s Modified Eagle’s medium (DMEM) (Life Technologies,
Texas, TX, USA) supplemented with 10% fetal bovine serum (Life Technologies, Texas, TX, USA) and
1% penicillin/streptomycin (Life Technologies, Texas, TX, USA) at 37 ◦C in a humidified atmosphere of
5% CO2/95% air in a Memmert ICO150med Incubator (Memmert, Schwabach, Germany). Cells were
divided into four groups and cultured in standard conditions (CTRL), on the GO nanofilm (GO), with
the addition of extract (1% of the medium) (E), and on the GO nanofilm with the addition of extract
(1% of the medium) (GO-E). Passages were not performed for the experimental primary cell cultures.
The medium was changed every 2 days.
The actual concentration of CEME added to the culture media was evaluated using Trypan Blue
assay (NanoEnTek, Massachusetts, MA, USA). Cells were maintained with 5, 2.5, and 1% CEME
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supplementation in standard DMEM. After 48 h of exposure to CEME, cells were detached with trypsin.
Then a suspension of cells in DMEM (10 µL) was mixed with trypan blue solution (10 µL). A mixture
of cells and stain (10 µL) was placed onto a cell counting slide and the total and live cell counts were
evaluated using an EVETM automatic cell counter (NanoEnTek, Massachusetts, MA, USA). The results
were compared to the control group that was maintained without the addition of CEME.
4.4. Cell Morphology
Cell morphology was observed and recorded using a light optical inverted microscope (TL-LED,
Leica Microsystems, Germany) and a Scanning Electron Microscope (SEM) (Quanta 200, FEI, Oregon,
OR, USA). Cells were fixed in ice cold methanol for 10 min at 4 ◦C and stained with eosin/hematoxylin.
For SEM imaging, cells were fixed after 5 days of primary cell culture with 2.5% glutaraldehyde in
phosphate-buffered saline (PBS) (Life Technologies, Texas, TX, USA). The samples were contrasted
with osmium tetroxide (Sigma-Aldrich, Missouri, MO, USA) and carbohydrazide (Sigma-Aldrich,
Missouri, MO, USA). The cells were then dehydrated in hexylene glycol (Sigma-Aldrich, Missouri, MO,
USA); drying was performed using a Polaron CPD 750l critical point dryer (Quorum Technologies,
Laughton, UK).
The spontaneous contractions of muscle cells were observed and counted manually from randomly
selected visual fields (n = 10) in real time (t = 1 min each series) using a light optical inverted microscope
(TL-LED, Leica Microsystems, Germany). Time-lapse of contractions were performed on a confocal
microscope (Olympus FV1000, Tokyo, Japan) with Nomarski contrast. Frames were captured every 6 s
for 15 min. Supplementary Video S1 was speeded up 300 times.
4.5. Cell Differentiation
The differentiation of cells was evaluated using a confocal microscope (Olympus FV1000, Tokyo,
Japan). For imaging, cells were fixed after 5 days of culture using 4% paraformaldehyde in PBS
(Life Technologies, Texas, TX, USA) for 10 min at room temperature and washed with ice-cold PBS.
Then cells were incubated in Triton X-100 (Sigma-Aldrich, Missouri, MO, USA) and washed with
PBS (Sigma-Aldrich, Missouri, MO, USA). Subsequently, cells were incubated with blocking solution,
i.e., normal goat serum (Chemicon International, California, CA, USA). Cell nuclei were stained with
4′,6-diamidino-2-phenylindole (DAPI) (Thermo Fisher Scientific, Massachusetts, MA, USA) and actin
filaments with phalloidin-Atto 633 (Sigma-Aldrich, Missouri, MO USA). After staining, the cells
were washed with PBS. The fusion index was calculated for the control group and cells with CEME
supplementation from randomly selected visual fields (n = 7) and presented as the number of nuclei in
the multinucleated myotubes divided by the total number of nuclei. The nuclei were counted manually.
4.6. LDH Assay
Cytotoxicity was evaluated using Cytotoxicity Detection Kit (Roche Diagnostics GmbH, Mannheim,
Germany) after 48 and 96 h of primary cell culture. For the GO and GO-E groups, 40 µL of GO solution
was dropped onto the bottom of the wells of 96-well microplates, dried, and incubated for 24 h with
DMEM before starting cell culture. Cells were cultured in 96-well plates (approximately 10 × 103 cells
per well for a test after 48 h, and 5 × 103 cells per well for a test after 96 h). The assay was performed
according to the manufacture’s protocol. The absorbance of samples (n = 8) was measured at 450 nm
using a Tecan Infinite 200 microplate reader (Tecan, Durham, NC, USA). The results were expressed as
a relative value (related to the control) after subtracting the absorbance from blank samples.
4.7. MTT Assay
Viability and proliferation were tested with a Vybrant Cell Proliferation Assay Kit (MTT) (Thermo
Fisher Scientific, Massachusetts, MA, USA) after 48 and 96 h of primary cell culture. For the GO and
GO-E groups, 40 µL of GO solution was dropped onto the bottom of the wells of 96-well microplates,
dried, and incubated for 24 h with DMEM before starting cell culture. Cells were cultured in 96-well
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plates (as described above). MTT reagent (10 µL) was added to each well and incubated for 3 h at 37 ◦C.
Next, lysis buffer (containing Isopropanol, Triton X, and HCl) was added to each well (100 µL). Culture
plates were centrifuged, and the supernatant was transferred to new 96-well plates. The absorbance of
samples (n = 8) was measured using Tecan Infinite 200 plate reader (Tecan, North Carolina, ND, USA)
at 570 nm, according to the manufacturer’s protocol.
4.8. Gene Expression
Gene expression at the mRNA level was measured using the quantitative polymerase chain
reaction method. The expression of ATP5B, FGF2, LDH5, PCNA, Myf5, MyoD1, MyoG, Pax3, and
Pax7 was examined, for calculations the GAPDH and ACTB housekeeping genes were used. All used
primers are presented in Table 2. After 5 days of primary cell culture, cells were detached with trypsin
and centrifuged at 1 200 rpm for 5 min. The cell pellet was homogenized using a TissueLyser ball
mill (Qiagen, Germantown, IL, USA). Total RNA was isolated using a NucleoSpin (Marcherey, Nagel,
Duren, Germany). Then, cDNA was synthesized with a Maxima First Strand cDNA Synthesis Kit
for RT-qPCR (Thermo Scientific, Wilmington, DE, USA). The Real-Time PCR (RT-PCR) was carried
out using a PowerUp SYBR Green Master Mix (Applied Biosystems, Michigan, MI, USA). The 2-∆∆CT
method was used to determine the results.
Table 2. Primers for gene expression analysis using RT-qPCR.
Genes Sequences (5′-3′)
PCNA
forward: TGCACGCATTTGTAGAGACC
reverse: AGTCAGCTGGACTGGCTCAT
FGF2
forward: GCACTGAAATGTGCAACAG
reverse: TCCAGGTCCAGTTTTTGGTC
LDH-5
forward: ATGCCCACAACAAGATCAG
reverse: CCTTTCAGCTTGTCCTCCAC
ATP5B
forward: GTTATTCGGTGTTCGCTGGT
reverse: TAGACCAGAGCGACCTTGG
Myf5 forward: CCAGGAGCTCTTGAGGGAAC
reverse: AGTCCGCCATCACATCGGAG
MyoD forward: GCTCTCGCAGGAGAAACAG
reverse: CTGGAGGCAGTATGGGACAT
MyoG forward: GCTGAAGAAGGTGAACGAA
reverse: CTGCTGGTTGAGGCTGCT
Pax3
forward: CCGTGCTAGATGGAGGAAGC
reverse: AGACACGGCTTGCGGTATG
Pax7
forward: CAGTAGAGACAGGCCAAGC
reverse: GGAGTTGGGAAGGAGTAGGG
GAPDH
forward: GAGGACCAGGTTGTCTCCTG
reverse: CCACAACACGGTTGCTGTAT
ACTB
forward: GTCCACCTTCCAGCAGATGT
reverse: ATAAAGCCATGCCAATCTCG
4.9. Statistics
Data were analyzed using two-factorial and monofactorial analysis of variance, ANOVA, and
StatGraphics Centurion version XVI (StatPoint Technologies, Georgia, GA, USA). Differences between
groups were tested with Tukey’s honest significant difference post hoc test. There were significant
differences between groups marked with different letters (a-b-c) and there were no significant differences
between groups marked with the same letters (a-a; b-b; c-c). The level of significance was set at p ≤ 0.05.
5. Conclusions
The GO nanofilm culture surface did not positively affect the differentiation or functional maturity
of differentiated muscle fibers; however, it did promote spontaneous contractions. The chicken embryo
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muscle extract, collected on day 18 of embryonic development, contained a cocktail protein that
influenced the intense differentiation of the muscle precursor cells collected on day 8 of embryo
development. Compared to the cells in the control group, a structure resembling a pseudo-tissue was
capable of spontaneous contractions, without the application of an electrical impulse. The addition
of chicken embryo muscle extract, to a concentration of about 1% of culture medium, may allow
researchers to culture pseudo-tissue muscle capable of spontaneous contraction. The study showed
that GO may be used as a niche for differentiating muscle cells, but the decisive influence on the
maturation of muscle tissue, especially muscle contractions, depends on the complexity of the applied
growth factors.
Supplementary Materials: The following are available online, Supplementary Table S1: The list of identified
protein in chicken embryo muscle extract (CEME) by LC-MS. Video S1: Spontaneous contraction activity of cells
with chicken embryo muscle extract (CEME) supplementation, 1 to 3 contractions per minute were noted, average
1.7 contraction per minute.
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